Novartis to pay $125M for blood-brain barrier crossing platform
Source ↗
👁 0
💬 0
Proceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” potential.
Comments (0)